This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Zhichao Zhang, Ph.D
Advisor, Bioproduct Research and Development at Eli Lilly & Company
Speaker

Profile

Zhichao is an Advisor in Bioproduct Research and Development at Eli Lilly. He works on control strategy and method development for peptides and oligonucleotides. He has supported molecules from first-in-human studies through Phase 3.

Agenda Sessions

  • Application of Accelerated Predictive Stability to siRNA Long Term Stability Assessment

    , 3:00pm
    View Session

At this event

Prev
Next
Marc Abrams, PhD
Chief Technology Officer & Head, US Operations
SanegeneBio

See Zhichao at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now